| Literature DB >> 24602414 |
Chonglin Luo1, Claudia E M Weber2, Wolfram Osen2, Anja-Katrin Bosserhoff3, Stefan B Eichmüller4.
Abstract
Melanoma is the most dangerous form of skin cancer, being largely resistant to conventional therapies at advanced stages. Understanding the molecular mechanisms behind this disease might be the key for the development of novel therapeutic strategies. MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally control gene expression, thereby regulating various cellular signaling pathways involved in the initiation and progression of different cancer types, including melanoma. In this review, we summarize approaches for the identification of candidate miRNAs and their target genes and review the functions of miRNAs in melanoma. Finally, we highlight the recent progress in pre-clinical use of miRNAs as prognostic markers and therapeutic targets.Entities:
Keywords: Bioinformatics; Diagnosis; Expression profiling; Melanoma; MicroRNA; Oncogene; Target identification; Therapy; Tumor marker; Tumor suppressor
Mesh：
Substances：
Year: 2014 PMID： 24602414 DOI： 10.1016/j.ejcb.2014.02.001
Source DB: PubMed Journal: Eur J Cell Biol ISSN： 0171-9335 Impact factor: 4.492